PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32973300-7	2020	CONCLUSION: These results provide the most comprehensive data set of DPYD and TPMT variability published to date with important implications for population-adjusted genetic profiling strategies of fluoropyrimidine and thiopurine risk factors and precision public health.	2-mercaptopyrazine	218-228	dihydropyrimidine dehydrogenase	Homo sapiens	69-73	
28262261-3	2017	This review presents the usefulness of pharmacogenetic tests for some key applications: dihydropyrimidine dehydrogenase (DPYD) genotyping for fluoropyrimidine (5-fluorouracil, capecitabine), UDP glucuronosylstransferase (UGT1A1) for irinotecan and thiopurine S-methyltransferase (TPMT) for thiopurine drugs.	2-mercaptopyrazine	248-258	dihydropyrimidine dehydrogenase	Homo sapiens	88-119	
28262261-3	2017	This review presents the usefulness of pharmacogenetic tests for some key applications: dihydropyrimidine dehydrogenase (DPYD) genotyping for fluoropyrimidine (5-fluorouracil, capecitabine), UDP glucuronosylstransferase (UGT1A1) for irinotecan and thiopurine S-methyltransferase (TPMT) for thiopurine drugs.	2-mercaptopyrazine	248-258	dihydropyrimidine dehydrogenase	Homo sapiens	121-125	
20037211-0	2009	TPMT and DPD polymorphisms: Efficient screening method for Indian patients considering taking Thiopurine and 5-FU drugs.	2-mercaptopyrazine	94-104	dihydropyrimidine dehydrogenase	Homo sapiens	9-12